4-(2,5-二氯苯基)-4-氧代丁酸 | 52240-14-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4-(2,5-二氯苯基)-4-氧代丁酸
• 英文名称: 4-(2,5-dichlorophenyl)-4-oxobutanoic acid
• 英文别名: 3-(2,5-Dichlorbenzoyl)-propionsaeure；4-(2,5-Dichlorophenyl)-4-oxobutyric acid
• CAS: 52240-14-9
• 化学式: C₁₀H₈Cl₂O₃
• mdl: MFCD02260935
• 分子量: 247.078
• InChiKey: FZLOKTSWFCRCNC-UHFFFAOYSA-N

物化性质

• 沸点：
  404.4±40.0 °C(Predicted)
• 密度：
  1.432±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2918300090

文献信息

• Compounds and Compositions for Delivering Active Agents
  申请人：Gomez-Orellana Maria Isabel

  公开号：US20080255250A1

  公开（公告）日：2008-10-16

  Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.

  提供用于传递活性成分的化合物和组合物。同时提供了管理和制备的方法。
• ARYL KETONE COMPOUNDS AND COMPOSITIONS FOR DELIVERING ACTIVE AGENTS
  申请人：Rath Parshuram

  公开号：US20080167217A1

  公开（公告）日：2008-07-10

  The present invention provides aryl ketone compounds and compositions containing them which facilitate the delivery of active agents. The aryl ketone compounds have the formula or a salt thereof, where n=1 to 9, and R 1 to R 5 are independently hydrogen, C 1 to C 4 alkyl, C 1 to C 4 alkoxy, C 2 to C 4 alkenyl, halogen, hydroxyl, —NH—C(O)—CH 3 , or —O—C 6 H 5 .

  本发明提供了含有芳基酮化合物和组成物的方法，可以促进活性剂的传递。芳基酮化合物的化学式为或其盐，其中n = 1至9，R1至R5独立地为氢，C1至C4烷基，C1至C4烷氧基，C2至C4烯基，卤素，羟基，—NH—C（O）—CH3或—O—C6H5。
• Compounds and compositions for delivering active agents
  申请人：Emisphere Technologies, Inc.

  公开号：EP2279732A2

  公开（公告）日：2011-02-02

  Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well.

  提供了用于递送活性剂的化合物和组合物。还提供了给药和制备方法。
• COMPOSITIONS OF PENTOSAN POLYSULFATE SALTS FOR ORAL ADMINISTRATION AND METHODS OF USE
  申请人：Urigen Pharmaceuticals, Inc.

  公开号：EP3110427A1

  公开（公告）日：2017-01-04
• COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES AND CONDITIONS EMPLOYING ORAL ADMINISTRATION OF SODIUM PENTOSAN POLYSULFATE AND OTHER PENTOSAN POLYSULFATE SALTS
  申请人：PARSONS C. Lowell

  公开号：US20170189443A1

  公开（公告）日：2017-07-06

  The present invention is directed to a pharmaceutical composition comprising: (1) a therapeutically effective quantity of sodium pentosan polysulfate; (2) a quantity of a penetration enhancer sufficient to improve the bioavailability of the sodium pentosan polysulfate; and (3) optionally, a pharmaceutically acceptable carrier and to methods for the oral administration of sodium pentosan polysulfate with improved bioavailability for the treatment of interstitial cystitis and other urinary tract diseases and conditions. Such compositions and methods allow the administration of sodium pentosan polysulfate at lower dosages to reduce the frequency and severity of side effects.